Arch Therapeutics (OTCMKTS:ARTH) Stock Crosses Below 50 Day Moving Average – Time to Sell?

Arch Therapeutics, Inc. (OTCMKTS:ARTHGet Free Report)’s share price passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.22 and traded as low as $0.17. Arch Therapeutics shares last traded at $0.17, with a volume of 136 shares.

Arch Therapeutics Stock Up 0.1 %

The business’s fifty day simple moving average is $0.22 and its two-hundred day simple moving average is $0.47.

Arch Therapeutics Company Profile

(Get Free Report)

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.

Featured Articles

Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.